News & Events | News

Thursday 16th November 2006

SJ Berwin LLP is pleased to announce that it has nominated the Cystic Fibrosis Trust as its Charity of the Year.

The Cystic Fibrosis Trust is the UK's only national charity working to fund research into a cure and to ensure appropriate clinical care and support for people with Cystic Fibrosis (CF), the UK's most common life-threatening inherited disease.

The main aim of the partnership between SJ Berwin LLP and the Cystic Fibrosis Trust is to raise money to fund the training of a Cystic Fibrosis consultant at the Brompton Hospital in London, providing much needed specialist care for people with CF both today and in the future.

Niamh Grogan, the Partner responsible for the firm's relationship with CF Trust, said: "We are very excited and proud to be working alongside the Cystic Fibrosis Trust and have already received tremendous support, enthusiasm and fundraising ideas from staff around the firm.  We have very high hopes for raising a considerable amount of money and awareness for this well deserved cause and truly hope to help make a significant improvement to the lives of people with CF."

Commenting on the new partnership, Sarah Guthrie, Director of Fundraising at Cystic Fibrosis Trust, said: "We are thrilled to join with SJ Berwin LLP in this new partnership and look forward to a year of income and awareness raising.  The training of a specialist consultant will make a big difference in the lives of many young adults with Cystic Fibrosis now and in the years to come." 

For further information, please contact: 

Niamh Grogan, Partner on +44 (0)20 7111 2115 or by emailing niamh.grogan@sjberwin.com 

Helen Thornhill, Head of Marketing on +44 (0)20 7111 5770 or by emailing helen.thornhill@sjberwin.com 

Dawn Haynes, Charity Officer on +44 (0)20 7111 5340 or by emailing dawn.haynes@sjberwin.com

To view other press releases click here.

• Founded in 1982, SJ Berwin is a leading City corporate and commercial law firm with more than 550 lawyers working across its offices in London, Berlin, Brussels, Frankfurt, Madrid, Milan, Munich, Paris and Turin.
  
  
• SJ Berwin was created and thrives as a leading-edge legal services business, focusing on the European and international market place.  Our clients are sophisticated buyers of legal services, principally entrepreneurial companies and financial institutions, whom we advise on a comprehensive range of services including Corporate Finance, Commercial, Real Estate, Banking, Reconstruction & Insolvency, Financial Services, Litigation, Employment & Pensions, EU & Competition and Tax.
  
  
• Our approach has resulted in the firm winning a number of recent awards including "UK Firm of the Year" at the 2005 Legal Week Awards, "Law Firm of the Year" 2005 at the EVCA/Real Deals European Private Equity Awards for the second successive year, "European Law Firm of the Year" (fund formation) by subscribers to PrivateEquityOnline and Private Equity International, "Private Equity Law Firm of the Year 2004"  at the European Venture Capital journal awards 2004 and 2005, "LBO Firm of the Year" 2004 at the Finance and Law Awards in Paris, "Real Estate Team of the Year" at The Lawyer Awards 2004, and "World's Leading Firm for Private Funds Expertise" in The International Who's Who of Business Lawyers 2003/4.
  
  
• On 1 June 2005, SJ Berwin became SJ Berwin LLP, a limited liability partnership. www.sjberwin.com. SJ Berwin LLP or an affiliated undertaking has an office in Berlin, Brussels, Frankfurt, London, Madrid, Milan, Munich, Paris and Turin.
  
  
• Founded in 1964, the Cystic Fibrosis Trust  (www.cftrust.org.uk) is the UK's only national charity working to fund research into a cure and to ensure appropriate clinical care and support for people with Cystic Fibrosis.
  
  
• Cystic Fibrosis is the UK's most common life-threatening inherited disease. It is caused by a defective gene, leading to a thick, sticky mucus that obstructs the airways, the digestive system and other organs, resulting in chronic infections and inflammation in the lungs and difficulty digesting food and nutrients.
  
  
• Each week five babies are born with Cystic Fibrosis (CF) and three people a week die from CF (90% from lung disease). The average life expectancy is currently 31 years old.
  
  
• One person in 25 is a carrier of the faulty CF gene, which is more than 2.3 million people in the UK.
  
  
• The Cystic Fibrosis Trust is currently investing over £3 million a year to fund its unique gene therapy programme to replace or repair the faulty gene in the lungs.